EMS-CHEMIE HOLDING AG Logo

EMS-CHEMIE HOLDING AG

0QM9.L

(0.0)
Stock Price

730,00 CHF

19.55% ROA

24.26% ROE

34.6x PER

Market Cap.

15.951.298.000,00 CHF

1.34% DER

3.3% Yield

20.68% NPM

EMS-CHEMIE HOLDING AG Stock Analysis

EMS-CHEMIE HOLDING AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

EMS-CHEMIE HOLDING AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

EMS-CHEMIE HOLDING AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

EMS-CHEMIE HOLDING AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

EMS-CHEMIE HOLDING AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

EMS-CHEMIE HOLDING AG Revenue
Year Revenue Growth
2002 1.337.508.000
2003 1.323.148.000 -1.09%
2004 1.149.035.000 -15.15%
2005 1.253.330.000 8.32%
2006 1.395.946.000 10.22%
2007 1.604.679.000 13.01%
2008 1.559.968.000 -2.87%
2009 1.181.137.000 -32.07%
2010 1.595.603.000 25.98%
2011 1.657.676.000 3.74%
2012 1.755.363.000 5.57%
2013 1.918.879.000 8.52%
2014 2.002.551.000 4.18%
2015 1.931.901.000 -3.66%
2016 2.011.902.000 3.98%
2017 2.176.569.000 7.57%
2018 2.349.583.000 7.36%
2019 2.152.739.000 -9.14%
2020 1.802.348.000 -19.44%
2021 2.253.846.000 20.03%
2022 2.441.909.000 7.7%
2023 2.366.000.000 -3.21%
2023 2.188.967.000 -8.09%
2024 4.346.520.000 49.64%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

EMS-CHEMIE HOLDING AG Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 39.962.000 100%
2014 44.079.000 9.34%
2015 42.871.000 -2.82%
2016 46.053.000 6.91%
2017 49.693.000 7.32%
2018 53.792.000 7.62%
2019 51.181.000 -5.1%
2020 45.956.000 -11.37%
2021 46.292.000 0.73%
2022 46.646.000 0.76%
2023 0 0%
2023 46.162.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

EMS-CHEMIE HOLDING AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 263.446.000
2003 266.171.000 1.02%
2004 38.264.000 -595.62%
2005 35.683.000 -7.23%
2006 56.374.000 36.7%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 32.778.000 100%
2013 35.649.000 8.05%
2014 32.286.000 -10.42%
2015 29.408.000 -9.79%
2016 37.110.000 20.75%
2017 36.689.000 -1.15%
2018 37.276.000 1.57%
2019 34.795.000 -7.13%
2020 25.460.000 -36.67%
2021 26.657.000 4.49%
2022 27.811.000 4.15%
2023 0 0%
2023 30.049.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

EMS-CHEMIE HOLDING AG EBITDA
Year EBITDA Growth
2002 187.109.000
2003 -75.413.000 348.11%
2004 257.692.000 129.26%
2005 309.718.000 16.8%
2006 295.969.000 -4.65%
2007 518.155.000 42.88%
2008 383.142.000 -35.24%
2009 342.437.000 -11.89%
2010 362.483.000 5.53%
2011 356.304.000 -1.73%
2012 387.014.000 7.94%
2013 422.943.000 8.49%
2014 478.924.000 11.69%
2015 525.417.000 8.85%
2016 604.583.000 13.09%
2017 636.029.000 4.94%
2018 675.253.000 5.81%
2019 638.500.000 -5.76%
2020 556.868.000 -14.66%
2021 687.600.000 19.01%
2022 653.202.000 -5.27%
2023 612.000.000 -6.73%
2023 536.731.000 -14.02%
2024 1.275.732.000 57.93%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

EMS-CHEMIE HOLDING AG Gross Profit
Year Gross Profit Growth
2002 708.050.000
2003 676.453.000 -4.67%
2004 512.507.000 -31.99%
2005 528.804.000 3.08%
2006 594.837.000 11.1%
2007 666.218.000 10.71%
2008 617.901.000 -7.82%
2009 516.591.000 -19.61%
2010 665.870.000 22.42%
2011 669.998.000 0.62%
2012 684.789.000 2.16%
2013 745.021.000 8.08%
2014 823.178.000 9.49%
2015 838.357.000 1.81%
2016 922.756.000 9.15%
2017 951.757.000 3.05%
2018 1.015.835.000 6.31%
2019 696.128.000 -45.93%
2020 596.965.000 -16.61%
2021 729.663.000 18.19%
2022 713.925.000 -2.2%
2023 610.000.000 -17.04%
2023 594.992.000 -2.52%
2024 4.346.520.000 86.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

EMS-CHEMIE HOLDING AG Net Profit
Year Net Profit Growth
2002 164.902.000
2003 113.352.000 -45.48%
2004 183.426.000 38.2%
2005 177.134.000 -3.55%
2006 297.441.000 40.45%
2007 293.754.000 -1.26%
2008 215.210.000 -36.5%
2009 221.221.000 2.72%
2010 232.096.000 4.69%
2011 242.146.000 4.15%
2012 267.018.000 9.31%
2013 317.618.000 15.93%
2014 342.871.000 7.37%
2015 376.248.000 8.87%
2016 448.755.000 16.16%
2017 481.513.000 6.8%
2018 519.615.000 7.33%
2019 527.140.000 1.43%
2020 434.340.000 -21.37%
2021 550.320.000 21.08%
2022 532.100.000 -3.42%
2023 490.000.000 -8.59%
2023 457.578.000 -7.09%
2024 997.568.000 54.13%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

EMS-CHEMIE HOLDING AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 6
2003 4 -50%
2004 7 42.86%
2005 7 0%
2006 13 41.67%
2007 12 0%
2008 9 -33.33%
2009 10 0%
2010 10 0%
2011 10 10%
2012 11 9.09%
2013 14 15.38%
2014 15 7.14%
2015 16 12.5%
2016 19 15.79%
2017 21 5%
2018 22 9.09%
2019 23 0%
2020 19 -22.22%
2021 24 21.74%
2022 23 -4.55%
2023 21 -10%
2023 20 -5.26%
2024 43 54.76%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

EMS-CHEMIE HOLDING AG Free Cashflow
Year Free Cashflow Growth
2002 196.590.000
2003 64.901.000 -202.91%
2004 87.155.000 25.53%
2005 184.971.000 52.88%
2006 99.624.000 -85.67%
2007 96.321.000 -3.43%
2008 145.230.000 33.68%
2009 214.672.000 32.35%
2010 163.639.000 -31.19%
2011 153.774.000 -6.42%
2012 238.677.000 35.57%
2013 287.224.000 16.9%
2014 437.457.000 34.34%
2015 355.196.000 -23.16%
2016 414.843.000 14.38%
2017 393.520.000 -5.42%
2018 439.513.000 10.46%
2019 468.384.000 6.16%
2020 401.314.000 -16.71%
2021 376.927.000 -6.47%
2022 746.149.000 49.48%
2023 108.000.000 -590.88%
2023 572.242.000 81.13%
2024 193.104.000 -196.34%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

EMS-CHEMIE HOLDING AG Operating Cashflow
Year Operating Cashflow Growth
2002 255.811.000
2003 115.853.000 -120.81%
2004 139.262.000 16.81%
2005 233.439.000 40.34%
2006 162.764.000 -43.42%
2007 168.187.000 3.22%
2008 208.942.000 19.51%
2009 252.234.000 17.16%
2010 212.915.000 -18.47%
2011 229.632.000 7.28%
2012 282.902.000 18.83%
2013 344.333.000 17.84%
2014 489.501.000 29.66%
2015 409.641.000 -19.5%
2016 486.038.000 15.72%
2017 442.583.000 -9.82%
2018 499.321.000 11.36%
2019 552.453.000 9.62%
2020 472.132.000 -17.01%
2021 456.853.000 -3.34%
2022 840.115.000 45.62%
2023 124.000.000 -577.51%
2023 621.632.000 80.05%
2024 205.614.000 -202.33%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

EMS-CHEMIE HOLDING AG Capital Expenditure
Year Capital Expenditure Growth
2002 59.221.000
2003 50.952.000 -16.23%
2004 52.107.000 2.22%
2005 48.468.000 -7.51%
2006 63.140.000 23.24%
2007 71.866.000 12.14%
2008 63.712.000 -12.8%
2009 37.562.000 -69.62%
2010 49.276.000 23.77%
2011 75.858.000 35.04%
2012 44.225.000 -71.53%
2013 57.109.000 22.56%
2014 52.044.000 -9.73%
2015 54.445.000 4.41%
2016 71.195.000 23.53%
2017 49.063.000 -45.11%
2018 59.808.000 17.97%
2019 84.069.000 28.86%
2020 70.818.000 -18.71%
2021 79.926.000 11.4%
2022 93.966.000 14.94%
2023 16.000.000 -487.29%
2023 49.390.000 67.6%
2024 12.510.000 -294.8%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

EMS-CHEMIE HOLDING AG Equity
Year Equity Growth
2002 1.319.852.000
2003 1.476.078.000 10.58%
2004 1.118.198.000 -32.01%
2005 1.082.851.000 -3.26%
2006 1.102.713.000 1.8%
2007 1.276.652.000 13.62%
2008 975.302.000 -30.9%
2009 1.021.724.000 4.54%
2010 1.110.364.000 7.98%
2011 1.056.502.000 -5.1%
2012 1.151.155.000 8.22%
2013 1.199.312.000 4.02%
2014 1.268.211.000 5.43%
2015 1.311.806.000 3.32%
2016 1.427.781.999 8.12%
2017 1.550.410.000 7.91%
2018 1.644.662.000 5.73%
2019 1.685.645.000 2.43%
2020 1.624.250.000 -3.78%
2021 1.828.327.000 11.16%
2022 1.844.389.000 0.87%
2023 1.768.587.000 -4.29%
2023 2.057.000.000 14.02%
2024 2.027.316.000 -1.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

EMS-CHEMIE HOLDING AG Assets
Year Assets Growth
2002 3.166.935.000
2003 3.117.571.000 -1.58%
2004 2.592.480.000 -20.25%
2005 2.350.412.000 -10.3%
2006 2.328.604.000 -0.94%
2007 2.277.064.000 -2.26%
2008 1.679.427.000 -35.59%
2009 1.711.290.000 1.86%
2010 1.668.921.000 -2.54%
2011 1.634.318.000 -2.12%
2012 1.676.931.000 2.54%
2013 1.737.852.000 3.51%
2014 1.845.626.000 5.84%
2015 1.890.973.000 2.4%
2016 1.984.624.000 4.72%
2017 2.099.998.999 5.49%
2018 2.157.617.000 2.67%
2019 2.213.309.000 2.52%
2020 2.077.534.999 -6.54%
2021 2.324.676.000 10.63%
2022 2.316.000.000 -0.37%
2023 2.167.152.000 -6.87%
2023 2.459.000.000 11.87%
2024 2.415.330.000 -1.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

EMS-CHEMIE HOLDING AG Liabilities
Year Liabilities Growth
2002 1.847.083.000
2003 1.641.493.000 -12.52%
2004 1.474.282.300 -11.34%
2005 1.267.561.000 -16.31%
2006 1.225.891.000 -3.4%
2007 1.000.412.000 -22.54%
2008 704.125.000 -42.08%
2009 689.566.000 -2.11%
2010 558.557.000 -23.45%
2011 577.816.000 3.33%
2012 525.776.000 -9.9%
2013 538.540.000 2.37%
2014 577.415.000 6.73%
2015 579.167.000 0.3%
2016 556.842.000 -4.01%
2017 549.589.000 -1.32%
2018 512.955.000 -7.14%
2019 527.664.000 2.79%
2020 453.285.000 -16.41%
2021 496.349.000 8.68%
2022 471.611.000 -5.25%
2023 398.565.000 -18.33%
2023 402.000.000 0.85%
2024 388.014.000 -3.6%

EMS-CHEMIE HOLDING AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
89.47
Net Income per Share
19.71
Price to Earning Ratio
34.6x
Price To Sales Ratio
7.62x
POCF Ratio
27.54
PFCF Ratio
29.03
Price to Book Ratio
7.98
EV to Sales
7.47
EV Over EBITDA
28.1
EV to Operating CashFlow
26.98
EV to FreeCashFlow
28.44
Earnings Yield
0.03
FreeCashFlow Yield
0.03
Market Cap
15,95 Bil.
Enterprise Value
15,63 Bil.
Graham Number
194.65
Graham NetNet
34.44

Income Statement Metrics

Net Income per Share
19.71
Income Quality
1.26
ROE
0.25
Return On Assets
0.21
Return On Capital Employed
0.26
Net Income per EBT
0.93
EBT Per Ebit
1
Ebit per Revenue
0.22
Effective Tax Rate
0.07

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.39
Operating Profit Margin
0.22
Pretax Profit Margin
0.22
Net Profit Margin
0.21

Dividends

Dividend Yield
0.03
Dividend Yield %
3.3
Payout Ratio
1.01
Dividend Per Share
22.5

Operating Metrics

Operating Cashflow per Share
24.77
Free CashFlow per Share
23.49
Capex to Operating CashFlow
0.05
Capex to Revenue
0.01
Capex to Depreciation
0.57
Return on Invested Capital
0.23
Return on Tangible Assets
0.2
Days Sales Outstanding
60.78
Days Payables Outstanding
81.23
Days of Inventory on Hand
423.68
Receivables Turnover
6
Payables Turnover
4.49
Inventory Turnover
0.86
Capex per Share
1.27

Balance Sheet

Cash per Share
28,33
Book Value per Share
86,68
Tangible Book Value per Share
84.24
Shareholders Equity per Share
85.44
Interest Debt per Share
1.31
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-0.59
Current Ratio
5.55
Tangible Asset Value
1,97 Bil.
Net Current Asset Value
1,25 Bil.
Invested Capital
1998061000
Working Capital
1,34 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,36 Bil.
Average Payables
0,10 Bil.
Average Inventory
516663000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

EMS-CHEMIE HOLDING AG Dividends
Year Dividends Growth
2006 7
2012 7 14.29%
2013 10 30%
2014 11 9.09%
2015 12 8.33%
2016 15 20%
2017 17 11.76%
2022 21 19.05%
2023 20 -5%

EMS-CHEMIE HOLDING AG Profile

About EMS-CHEMIE HOLDING AG

EMS-CHEMIE HOLDING AG engages in the high performance polymers and specialty chemicals businesses worldwide. The company's High Performance Polymers segment is involved in the manufacture and supply of high-performance polyamides granulates. Its Specialty Chemicals segment develops, produces, and sells fibers, bonding agent for tires, fusible adhesives, and adhesive yarns for technical and textile applications; powder coatings; and reactive diluents. The company also offers bonding, coating, sealing, and damping systems; and hotmelt adhesives, crosslinkers, epoxy systems, technical fibers, adhesion promoters, and fusible bonding yarns and granules. It serves automotive, electro and electronic, industry and consumer goods, optic, and packaging markets. The company was founded in 1936 and is based in Domat/Ems, Switzerland. EMS-CHEMIE HOLDING AG is a subsidiary of EMESTA HOLDING AG.

CEO
Ms. Magdalena Martullo-Bloche
Employee
2.736
Address
Via Innovativa 1
Domat/Ems, 7013

EMS-CHEMIE HOLDING AG Executives & BODs

EMS-CHEMIE HOLDING AG Executives & BODs
# Name Age
1 Mr. Oliver Minger
Chief Financial Officer & Member of Executive Management
70
2 Mr. Peter Germann
Member of Executive Management
70
3 Mr. Urs Janssen
Member of Executive Management
70
4 Ms. Magdalena Martullo-Blocher
Vice-Chairman, Chief Executive Officer & Member of Executive Management
70
5 Dr. Christoph Kleiner
Member of Management Board
70

EMS-CHEMIE HOLDING AG Competitors